 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Bone Care International, Inc.
 |
Bone Care International, Inc. |
 |
 |
 |
PROFILE |
 |
Marrow-minded Bone Care International is developing improved vitamin D hormones for treating secondary hyperparathyroidism in patients with kidney disease, osteoporosis, psoriasis, prostate cancer, colon cancer, and breast cancer. Its main products -- Hectorol, Hectorol Injection, and Hectorol Capsules -- are used to prevent excessive hormone production in the parathyroid glands of renal disease patients; Hectorol Capsules are also being developed to treat this condition in pre-dialysis patients. Bone Care International markets Hectorol directly in the US, and is seeking collaborative partners for distribution abroad. Founder and chairman Richard Mazess owns nearly 30% of the company.
COMPETITION |
 |
Mission Pharmacal (dossier)
NPS Pharmaceuticals, Inc. (NPSP)
Unigene Laboratories, Inc. (UGNE)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
2000 Sales (mil.): 0.40
1-Yr. Sales Growth: 300.0%
Employees: 66
Revenue per employee: $6,060.61
KEY PEOPLE |
 |
Charles W. Bishop
CEO
Dale W. Gutman
CFO
CONTACT INFO |
 |
1 Science Ct.
Madison, WI 53711
US
Phone: 608-236-2500
Fax: 608-236-2525
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |